Article
Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.
Oncotarget - 17 Jun 2025
Fei Fei, Telatar Milhan, Tomasian Vanina, Chang Lisa, Danilova Olga, Arias-Stella Javier, Pillai Raju, Soma Lorinda, Tizro Parastou, Becker Pamela S, Stein Anthony S, Marcucci Guido, Afkhami Michelle
Abstract excerpt
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy with poorly characterized molecular features. To identify disease-specific mutational profiles, we performed targeted next-generation sequencing (NGS) on a cohort of 21 BPDCN patients. Our study revealed that TET2 (57%) and ASXL1 (33%) were the most frequently mutated genes, followed by NRAS (29%), SRSF2 (14%), ZRSR2 (14%),...
Topics
- Humans
- Male
- Aged
- Female
- Middle Aged
- Dendritic Cells
- Hematologic Neoplasms
- Mutation
- Adult
- Dioxygenases
- High-Throughput Nucleotide Sequencing
